Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  New England Journal of Medicine

• Publication date

  1985-07-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM198507043130102PMID 2582256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.

  1985cited by this paper
• Relevance of reduced concentrations of somatostatin in Alzheimer's disease

  1985cited by this paper
• 5-Hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid and caudate nucleus of histologically verified examples of Alzheimer's disease

  1985cited by this paper
• Psychological Correlates in Presenile Dementia

  1985cited by this paper
• Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer‐Type Dementia

  1984cited by this paper
• Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.

  1984cited by this paper
• Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.

  1984cited by this paper
• Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.

  1984cited by this paper
• Neurochemical characteristics of early and late onset types of Alzheimer's disease.

  1984cited by this paper
• Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type.

  1984cited by this paper
• Nucleus Raphe Dorsalis in Dementia of the Alzheimer Type: Neurofibrillary Changes and Neuronal Packing Density

  1984cited by this paper
• Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

  1983cited by this paper
• Presynaptic Cholinergic Dysfunction in Patients with Dementia

  1983cited by this paper
• Monoamine metabolism in senile dementia of Alzheimer type.

  1983cited by this paper
• Metabolic Processes in Alzheimer's Disease: Adenine Nucleotide Content and Production of 14CO2 from [U‐14C]Glucose In Vitro in Human Neocortex

  1983cited by this paper
• Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease.

  1983cited by this paper
• Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT).

  1983cited by this paper
• Plaques, tangles and dementia. A quantitative study.

  1982cited by this paper
• Stimulation of acetylcholine synthesis by blockade of presynaptic muscarinic inhibitory autoreceptors: observations in rat and human brain preparations and comparison with the effect of choline.

  1982cited by this paper
• Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.

  1982cited by this paper
• [14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex.

  1981cited by this paper
• Some morphometric aspects of the brain in senile dementia of the alzheimer type

  1981cited by this paper
• Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

  1981cited by this paper
• Treatment of Alzheimer's disease: a cautionary note.

  1981cited by this paper
• Simultaneous determination of catecholamines and unconjugated 3,4-dihydroxyphenylacetic acid in brain tissue by ion-pairing reverse-phase high-performance liquid chromatography with electrochemical detection.

  1980cited by this paper
• Amygdaloid changes in aging and dementia.

  1980cited by this paper
• Neurochemical observations in a case of Pick's disease.

  1980cited by this paper
• Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.

  1980cited by this paper
• Accelerated ageing or selective neuronal loss as an important cause of dementia?

  1979cited by this paper
• Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia

  1977cited by this paper
• Selective vulnerability of neurones in organic dementia

  1977cited by this paper

• Computational insights and experimental breakthroughs in identifying next-generation acetylcholinesterase inhibitors

  2025cites this paper
• Review on anti-alzheimer drug development: approaches, challenges and perspectives

  2024cites this paper
• Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease

  2024cites this paper
• Tyrosinase-induced neuromelanin accumulation triggers rapid dysregulation and degeneration of the mouse locus coeruleus

  2023cites this paper
• Mitochondrial Dysfunction Links to Impaired Hippocampal Serotonin Release in a Mouse Model of Alzheimer’s Disease

  2023cites this paper
• Beyond cardiovascular risk: Implications of Familial Hypercholesterolemia on cognition and brain function.

  2023cites this paper
• Mitochondrial Interaction with Serotonin in Neurobiology and Its Implication in Alzheimer’s Disease

  2023cites this paper
• Mechanisms and structure-activity relationships of polysaccharides in the intervention of Alzheimer's disease: A review.

  2023cites this paper
• Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease

  2022cites this paper
• The Neurotoxin DSP-4 Dysregulates the Locus Coeruleus-Norepinephrine System and Recapitulates Molecular and Behavioral Aspects of Prodromal Neurodegenerative Disease

  2022cites this paper
• In vitro studies of a series of synthetic compounds for their anti-acetylcholinesterase activities identified arylpyrano[2,3-f]coumarins as hit compounds.

  2022cites this paper
• Nanoporous gold: A review and potentials in biotechnological and biomedical applications

  2021cites this paper
• Examining the Role of the Noradrenergic Locus Coeruleus for Predicting Attention and Brain Maintenance in Healthy Old Age and Disease: An MRI Structural Study for the Alzheimer’s Disease Neuroimaging Initiative

  2021cites this paper
• MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities

  2021cites this paper
• Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders

  2021cites this paper
• The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer’s Disease

  2021cites this paper
• Examining the Role of the Noradrenergic Locus Coeruleus for Predicting Attention and Brain Maintenance in Healthy Old Age, Mild Cognitive Impairment and Alzheimer’s Disease: An MRI Structural Study On the Adni Cohort

  2021cites this paper
• Neuroprotective Efficacy of Apple Cider Vinegar on Zinc-High Fat Diet-Induced Mono Amine Oxidase Alteration in Murine Model of AD.

  2021cites this paper
• Topographical Distribution of Consecutive Cholinergic Transmission Deficit in Patients Suspected of Dementia Disease

  2020cites this paper
• Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use

  2020cites this paper
• Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease

  2019cites this paper
• Beta-amyloid short- and long-term synaptic entanglement.

  2019cites this paper
• Brains for Dementia Research: The Importance of Cohorts in Brain Banking

  2019cites this paper
• A C-terminal peptide from secreted amyloid precursor protein-α enhances long-term potentiation in rats and a transgenic mouse model of Alzheimer's disease.

  2019cites this paper
• Comparison of Mini Mental Score Examination, Quantitative Electroencephalography and Cerebrospinal Fluid Biomarkers in Clinical Practice Examining Dementia

  2019cites this paper
• Comparison of Cholinergic Status with Quantitative EEG in Healthy Subjects and Patients Suspected of Dementia

  2019cites this paper
• Alzheimer’s disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms

  2019cites this paper
• Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research

  2018cites this paper
• In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease.

  2018cites this paper
• Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages

  2018cites this paper
• Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer’s-like disease in mice

  2017cites this paper
• Effect of aging and Alzheimer's disease‐like pathology on brain monoamines in mice

  2017cites this paper
• Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging.

  2017cites this paper
• WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.

  2017cites this paper
• Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer’s Disease Pathogenesis

  2015cites this paper
• Studies of amyloid toxicity in Drosophila models and effects of the BRICHOS domain

  2015cites this paper
• Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease

  2014cites this paper
• The Acetylcholine Index: An Electroencephalographic Marker of Cholinergic Activity in the Living Human Brain Applied to Alzheimer's Disease and Other Dementias

  2014cites this paper
• Outline of therapeutic interventions with muscarinic receptor-mediated transmission.

  2014cites this paper
• Chronic Aluminum Intake Causes Alzheimer's Disease: Applying Sir Austin Bradford Hill's Causality Criteria

  2014cites this paper
• acilitation of memory impairment and cholinergic disturbance in a mouse odel of Alzheimer ’ s disease by mild ischemic burden

  2013cites this paper
• Nerve Growth Factor-Mediated Regulation of Low Density Lipoprotein Receptor-Related Protein Promoter Activation

  2013cites this paper
• EFFECTS OF ALUMINIUM CHLORIDE EXPOSURE ON THE HISTOLOGY OF KIDNEY OF WISTAR RATS

  2013cites this paper
• Specialist Medical Review Council Re: Statements of Principles Nos. 22 & 23 of 2010 for Alzheimer-type Dementia Request for Review Declaration No. 21

  2013cites this paper
• Drain of the brain: low-affinity p75 neurotrophin receptor affords a molecular sink for clearance of cortical amyloid β by the cholinergic modulator system.

  2013cites this paper
• Effects of Aluminium Chloride Exposure on the Histology of lungs of

  2013cites this paper
• Effect of Methylphenidate on Attention in Apathetic Alzheimer’s Disease Patients and Association with Apathy Changes in a Randomized, Placebo-controlled Trial

  2013cites this paper
• Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease

  2013cites this paper
• The impact of acetylcholinesterase inhibitors on the extracellular acetylcholine concentrations in the adult rat brain: A meta‐analysis

  2012cites this paper
• Terpenoids as Potential Anti-Alzheimer’s Disease Therapeutics

  2012cites this paper
• Impaired Attention in the 3xTgAD Mouse Model of Alzheimer's Disease: Rescue by Donepezil (Aricept)

  2011cites this paper
• Animal Models in Neuroscience

  2011cites this paper
• Alzheimer's Disease – Not an Exaggeration of Healthy Aging

  2011cites this paper
• A putative role for PCSK9 in synaptic remodelling and plasticity in response to brain injury: implications for Alzheimer's disease

  2011cites this paper
• Impact of Oxidative - Nitrosative Stress on Cholinergic Presynaptic Function

  2011cites this paper
• 24-Month effect of smoking cessation on cognitive function and brain structure in later life

  2011cites this paper
• David Bowen, 1940-2011 OBITUARY

  2011cites this paper
• Role of Thiamine in Alzheimer's Disease

  2011cites this paper
• Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice.

  2010cites this paper
• Galantamine for Alzheimer's disease

  2010cites this paper
• Neurochemical changes in a double transgenic mouse model of Alzheimer's disease fed a pro-oxidant diet.

  2010cites this paper
• The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project

  2010cites this paper
• Neurochemical basis for symptomatic treatment of Alzheimer's disease.

  2010cites this paper
• Neurochemistry of Alzheimer's Disease

  2010cites this paper
• Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease.

  2010cites this paper
• Structure and properties of drug-loaded polymeric nanoparticles targeting β-amyloid

  2010cites this paper
• Nicotine increases the expression of neurotrophin receptor tyrosine kinase receptor A in basal forebrain cholinergic neurons.

  2010cites this paper
• G Protein–Coupled Receptors, Cholinergic Dysfunction, and Aβ Toxicity in Alzheimer’s Disease

  2009cites this paper
• Importance and prospects for design of selective muscarinic agonists.

  2008cites this paper
• Cortical Cholinergic Lesion Causes Aβ Deposition: Cholinergic-Amyloid Fusion Hypothesis

  2008cites this paper
• Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice.

  2008cites this paper
• Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease.

  2007cites this paper
• Altered synaptic function in Alzheimer's disease.

  2006cites this paper
• Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.

  2006cites this paper
• Biomarkers in the Diagnosis of Alzheimer’s Disease: Are We Ready?

  2006cites this paper
• Muscarinic Receptor Antagonists in Rats

  2006cites this paper
• Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.

  2006cites this paper
• The amyloid pathology progresses in a neurotransmitter-specific manner.

  2006cites this paper
• Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: the cholinergic-vascular hypothesis.

  2006cites this paper
• Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.

  2005cites this paper
• Physostigmine restores3H-acetylcholine efflux from Alzheimer brain slices to normal level

  2005cites this paper
• Neurochemistry of Alzheimer’s disease

  2005cites this paper
• Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.

  2005cites this paper
• Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity

  2005cites this paper
• Cortical Cholinergic Deafferentation Induces Aβ Deposition

  2005cites this paper
• Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats

  2005cites this paper
• Comments on “Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-d-aspartate Receptors in Rat Hippocampal Neurons”

  2005cites this paper
• Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-D-aspartate Receptors in Rat Hippocampal Neurons

  2005cites this paper
• The Interplay of Neurotransmitters in Alzheimer's Disease

  2005cites this paper
• Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile

  2005cites this paper
• Velnacrine for the treatment of Alzheimer's disease: A double-blind, placebo-controlled trial

  2005cites this paper
• Dopaminergic and Glutamatergic Systems in Alzheimer’s Disease

  2005cites this paper
• Monoamine neurons in aging and Alzheimer's disease

  2005cites this paper
• Response: Comments on “Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-d-aspartate Receptors in Rat Hippocampal Neurons”

  2005cites this paper
• Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB

  2005cites this paper
• Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease

  2004cites this paper
• Growth hormone response to clonidine predicts aggression in Alzheimer's disease.

  2004cites this paper
• Functional neurochemistry of Alzheimer's disease.

  2004cites this paper
• The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

  2004cites this paper
• Cognitive effects of l-deprenyl in Alzheimer's disease

  2004cites this paper